tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 247 are a BUY (95%), 11 are a HOLD (4.23%), 2 are a SELL (0.77%).
Analyst Steven Seedhouse, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 43.21% that have a potential upside of 68.36% achieved within 342 days.
Steven Seedhouse’s has documented 465 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ETNB, 89bio at 19-Sep-2025.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$205
$22.5 (12.33%)
4 years 5 months 6 days ago
(04-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 5 months 8 days ago
(02-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 5 months 15 days ago
(25-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy
$175
$-7.5 (-4.11%)
$165
4 years 8 months 7 days ago
(03-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold
$166
$-16.5 (-9.04%)
$175
4 years 8 months 7 days ago
(03-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
